1,213 research outputs found
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia
Background:
Over the past decade genome-wide association studies (GWAS) have been applied to aid in the understanding of the biology of traits. The success of this approach is governed by the underlying effect sizes carried by the true risk variants and the corresponding statistical power to observe such effects given the study design and sample size under investigation. Previous ASD GWAS have identified genome-wide significant (GWS) risk loci; however, these studies were of only of low statistical power to identify GWS loci at the lower effect sizes (odds ratio (OR) <1.15).
Methods:
We conducted a large-scale coordinated international collaboration to combine independent genotyping data to improve the statistical power and aid in robust discovery of GWS loci. This study uses genome-wide genotyping data from a discovery sample (7387 ASD cases and 8567 controls) followed by meta-analysis of summary statistics from two replication sets (7783 ASD cases and 11359 controls; and 1369 ASD cases and 137308 controls).
Results:
We observe a GWS locus at 10q24.32 that overlaps several genes including PITX3, which encodes a transcription factor identified as playing a role in neuronal differentiation and CUEDC2 previously reported to be associated with social skills in an independent population cohort. We also observe overlap with regions previously implicated in schizophrenia which was further supported by a strong genetic correlation between these disorders (Rg = 0.23; P = 9 × 10−6). We further combined these Psychiatric Genomics Consortium (PGC) ASD GWAS data with the recent PGC schizophrenia GWAS to identify additional regions which may be important in a common neurodevelopmental phenotype and identified 12 novel GWS loci. These include loci previously implicated in ASD such as FOXP1 at 3p13, ATP2B2 at 3p25.3, and a ‘neurodevelopmental hub’ on chromosome 8p11.23.
Conclusions:
This study is an important step in the ongoing endeavour to identify the loci which underpin the common variant signal in ASD. In addition to novel GWS loci, we have identified a significant genetic correlation with schizophrenia and association of ASD with several neurodevelopmental-related genes such as EXT1, ASTN2, MACROD2, and HDAC4
How alcohol makes the epigenetic clock tick faster and the clock reversing effect of abstinence
Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomains
Recently, 125 loci with genome-wide support for association with schizophrenia
were identified. We investigated the impact of these variants and their
accumulated genetic risk on brain activation in five neurocognitive domains of
the Research Domain Criteria (working memory, reward processing, episodic
memory, social cognition and emotion processing). In 578 healthy subjects we
tested for association (i) of a polygenic risk profile score (RPS) including
all single-nucleotide polymorphisms (SNPs) reaching genome-wide significance
in the recent genome-wide association studies (GWAS) meta-analysis and (ii) of
all independent genome-wide significant loci separately that showed sufficient
distribution of all allelic groups in our sample (105 SNPs). The RPS was
nominally associated with perigenual anterior cingulate and posterior
cingulate/precuneus activation during episodic memory (PFWE(ROI)=0.047) and
social cognition (PFWE(ROI)=0.025), respectively. Single SNP analyses revealed
that rs9607782, located near EP300, was significantly associated with amygdala
recruitment during emotion processing (PFWE(ROI)=1.63 × 10−4, surpassing
Bonferroni correction for the number of SNPs). Importantly, this association
was replicable in an independent sample (N=150; PFWE(ROI)<0.025). Other SNP
effects previously associated with imaging phenotypes were nominally
significant, but did not withstand correction for the number of SNPs tested.
To assess whether there was true signal within our data, we repeated single
SNP analyses with 105 randomly chosen non-schizophrenia-associated variants,
observing fewer significant results and lower association probabilities.
Applying stringent methodological procedures, we found preliminary evidence
for the notion that genetic risk for schizophrenia conferred by rs9607782 may
be mediated by amygdala function. We critically evaluate the potential caveats
of the methodological approaches employed and offer suggestions for future
studies
Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci
Alopecia areata (AA) is a prevalent autoimmune disease with 10 known susceptibility loci. Here we perform the first meta-analysis of research on AA by combining data from two genome-wide association studies (GWAS), and replication with supplemented ImmunoChip data for a total of 3,253 cases and 7,543 controls. The strongest region of association is the major histocompatibility complex, where we fine-map four independent effects, all implicating human leukocyte antigen-DR as a key aetiologic driver. Outside the major histocompatibility complex, we identify two novel loci that exceed the threshold of statistical significance, containing ACOXL/BCL2L11(BIM) (2q13); GARP (LRRC32) (11q13.5), as well as a third nominally significant region SH2B3(LNK)/ATXN2 (12q24.12). Candidate susceptibility gene expression analysis in these regions demonstrates expression in relevant immune cells and the hair follicle. We integrate our results with data from seven other autoimmune diseases and provide insight into the alignment of AA within these disorders. Our findings uncover new molecular pathways disrupted in AA, including autophagy/apoptosis, transforming growth factor beta/Tregs and JAK kinase signalling, and support the causal role of aberrant immune processes in AA
Temporal delay discounting in acutely ill and weight-recovered patients with anorexia nervosa
Background. Patients with anorexia nervosa (AN) are characterized by a very low body weight but readily give up immediate rewards (food) for long-term goals (slim figure), which might indicate an unusual level of self-control. This everyday clinical observation may be quantifiable in the framework of the anticipation-discounting dilemma. Method. Using a cross-sectional design, this study compared the capacity to delay reward in 34 patients suffering from acute AN (acAN), 33 weight-recovered AN patients (recAN) and 54 healthy controls. We also used a longitudinal study to reassess 21 acAN patients after short-term weight restoration. A validated intertemporal choice task and a hyperbolic model were used to estimate temporal discounting rates. Results. Confirming the validity of the task used, decreased delay discounting was associated with age and low selfreported impulsivity. However, no group differences in key measures of temporal discounting of monetary rewards were found. Conclusions. Increased cognitive control, which has been suggested as a key characteristic of AN, does not seem to extend the capacity to wait for delayed monetary rewards. Differences between our study and the only previous study reporting decreased delay discounting in adult AN patients may be explained by the different age range and chronicity of acute patients, but the fact that weight recovery was not associated with changes in discount rates suggests that discounting behavior is not a trait marker in AN. Future studies using paradigms with disorder-specific stimuli may help to clarify the role of delay discounting in AN
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Polygenic risk scores have shown great promise in predicting complex disease risk and will become more accurate as training sample sizes increase. The standard approach for calculating risk scores involves linkage disequilibrium (LD)-based marker pruning and applying a p value threshold to association statistics, but this discards information and can reduce predictive accuracy. We introduce LDpred, a method that infers the posterior mean effect size of each marker by using a prior on effect sizes and LD information from an external reference panel. Theory and simulations show that LDpred outperforms the approach of pruning followed by thresholding, particularly at large sample sizes. Accordingly, predicted R(2) increased from 20.1% to 25.3% in a large schizophrenia dataset and from 9.8% to 12.0% in a large multiple sclerosis dataset. A similar relative improvement in accuracy was observed for three additional large disease datasets and for non-European schizophrenia samples. The advantage of LDpred over existing methods will grow as sample sizes increase
HySenS data exploitation for urban land cover analysis
This paper addresses the use of HySenS airborne hyperspectral data for environmental urban monitoring. It is
known that hyperspectral data can help to characterize some of the relations between soil composition, vegetation
characteristics, and natural/artificial materials in urbanized areas. During the project we collected DAIS and
ROSIS data over the urban test area of Pavia, Northern Italy, though due to a late delivery of ROSIS data only
DAIS data was used in this work. Here we show results referring to an accurate characterization and classification
of land cover/use, using different supervised approaches, exploiting spectral as well as spatial information.
We demonstrate the possibility to extract from the hyperspectral data information which is very useful for environmental
characterization of urban areas
Runs of homozygosity implicate autozygosity as a schizophrenia risk factor
Autozygosity occurs when two chromosomal segments that are identical from a common ancestor are inherited from each parent. This occurs at high rates in the offspring of mates who are closely related (inbreeding), but also occurs at lower levels among the offspring of distantly related mates. Here, we use runs of homozygosity in genome-wide SNP data to estimate the proportion of the autosome that exists in autozygous tracts in 9,388 cases with schizophrenia and 12,456 controls. We estimate that the odds of schizophrenia increase by ~17% for every 1% increase in genome-wide autozygosity. This association is not due to one or a few regions, but results from many autozygous segments spread throughout the genome, and is consistent with a role for multiple recessive or partially recessive alleles in the etiology of schizophrenia. Such a bias towards recessivity suggests that alleles that increase the risk of schizophrenia have been selected against over evolutionary time
- …